Skip to content

BIO INX

Active
Private limited company·Speur- en ontwikkelingswerk op biotechnologisch gebied· 4 yrs active
Technologiepark-Zwijnaarde 66 ·9052 Gent, Belgium
BE 0784.459.685
Watch Print / PDF
Turnover
EBIT margin
Net result€-295k+11.1%
Working capital€1.14M+543.1%
CSV export

Annual accounts & ratios

Source: NBB · 2024
Annual accounts filed on 10-07-2025 with the NBB · fiscal year 2024 · verkort
€-400k€-300k€-200k€-100k€0Operating result 2023: €-330k€-330kNet result 2023: €-331k€-331kOperating result 2024: €-280k€-280kNet result 2024: €-295k€-295k20232024
Operating resultNet result
Sector comparison
Fiscal year 2024 · NACE 72 · compared across all schema types (micro, abbreviated and full combined)
Metric This company Sector median Position in the sector
Solvency 2.8% 59.4%
better than 25% of 52 sector peers
Net result €-295k €-440
better than 9% of 52 sector peers
Equity €49k €70k
better than 39% of 52 sector peers
Gross operating margin €-67k €7k
better than 8% of 53 sector peers
Total assets €1.74M €167k
better than 90% of 53 sector peers
Median and position computed from NBB annual accounts filed by sector peers; own figures from the latest filed accounts.
EBITDA
€-194k
+28.7% -911% vs sector
Net profit
€-295k
+11.1% -768% vs sector
Cash flow
€-209k
+23.6% -1241% vs sector
Total assets
€1.74M
+332.1% +754% vs sector
Equity
€49k
-74.6% -66% vs sector
Working capital
€1.14M
+543.1% +1396% vs sector
Employees (FTE)
3
+55.6% 23–24
Staff costs
€127k
-15.6% 23–24
Debt
€1.69M
+711.1% +2608% vs sector
Debt ≤ 1y
€251k
+189.7% +303% vs sector
Debt > 1y
€197k
+1152% vs sector
Current ratio
5.52
+81.8% +172% vs sector
Quick ratio
5.44
+79.2% +168% vs sector
Solvency
2.8%
-94.1% -96% vs sector
Debt / equity
34.24
+3092.1% +7642% vs sector
ROE
-597.6%
-250.0% -2220% vs sector
ROA
-17.0%
+79.4% -186% vs sector
Interest coverage
-11.67
+92.5% -127% vs sector
Figures by fiscal year
Fiscal year2024
Revenue
EBITDA€-194k
Net profit€-295k
Cash flow€-209k
Staff costs€127k
Income taxes
Dividends
Total assets€1.74M
Equity€49k
Debt€1.69M
of which ≤ 1y€251k
of which > 1y€197k
Working capital€1.14M
Employees (FTE)2.8
Ratios (computed)
2024
Current ratio5.52
Quick ratio5.44
Working capital ratio65.3%
Solvency2.8%
Debt / equity34.24
Long-term debt ratio3.99
Interest coverage-11.67
Gross margin
Net margin
ROA-17.0%
ROE-597.6%
EBITDA margin
Days sales outstanding
Days payable outstanding
Inventory turnover
Days inventory (DSI)
Balance-sheet composition 2024
Full annual accounts
Filed balance sheet and income statement, exactly as deposited with the NBB.
Line item Code2024
Balance sheet — Assets
TOTAL ASSETS 20/58€1.74M
Fixed assets 21/28€352k
Intangible fixed assets 21€13k
Tangible fixed assets 22/27€339k
Current assets 29/58€1.39M
Stocks & contracts in progress 3€20k
Amounts receivable within one year 40/41€301k
Cash & bank 54/58€382k
Balance sheet — Equity & liabilities
TOTAL EQUITY & LIABILITIES 10/49€1.74M
Equity 10/15€49k
Contributions / capital 10/11€676k
Accumulated profits (losses) 14€-626k
Amounts payable 17/49€1.69M
Amounts payable after one year 17€197k
Amounts payable within one year 42/48€251k
Trade debts payable within one year 44€53k
Income statement
Gross operating margin 9900€-67k
Operating result 9901€-280k
Financial income 75€2k
Financial charges 65€17k
Result before taxes 9903€-295k
Net result for the period 9904€-295k
Result to be appropriated 9905€-295k
You're seeing the latest fiscal year only. Unlock 1 prior year (figures + ratios) with a paid plan. See plans →
Ratios computed by Checked.

Health barometer

FY 2024 · computed
40 / 100 Weak
050100

Unlock the full score breakdown, per-year score history and the indicative credit limit from Starter.

See plans →
Computed by Checked from NBB filings and Belgian State Gazette signals. Indicative — not credit advice.